Scotia Capital Inc. Raises Stake in Aurora Cannabis Inc (NYSE:ACB)

Scotia Capital Inc. lifted its position in shares of Aurora Cannabis Inc (NYSE:ACB) by 19.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 191,413 shares of the company’s stock after buying an additional 30,643 shares during the quarter. Scotia Capital Inc.’s holdings in Aurora Cannabis were worth $1,494,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Mackey Komara & Dankovich LLC acquired a new stake in shares of Aurora Cannabis in the second quarter worth approximately $27,000. Executive Wealth Management LLC boosted its position in shares of Aurora Cannabis by 102.1% in the second quarter. Executive Wealth Management LLC now owns 3,900 shares of the company’s stock worth $30,000 after acquiring an additional 1,970 shares during the last quarter. Kistler Tiffany Companies LLC boosted its position in shares of Aurora Cannabis by 77.9% in the second quarter. Kistler Tiffany Companies LLC now owns 4,075 shares of the company’s stock worth $32,000 after acquiring an additional 1,785 shares during the last quarter. Resources Investment Advisors LLC. boosted its position in shares of Aurora Cannabis by 825.7% in the second quarter. Resources Investment Advisors LLC. now owns 4,962 shares of the company’s stock worth $39,000 after acquiring an additional 4,426 shares during the last quarter. Finally, Wealthcare Advisory Partners LLC boosted its position in shares of Aurora Cannabis by 71.8% in the first quarter. Wealthcare Advisory Partners LLC now owns 5,451 shares of the company’s stock worth $49,000 after acquiring an additional 2,278 shares during the last quarter. Institutional investors and hedge funds own 8.89% of the company’s stock.

Several equities research analysts recently issued reports on the stock. Stifel Nicolaus assumed coverage on shares of Aurora Cannabis in a research report on Wednesday, June 5th. They issued a “hold” rating on the stock. Bank of America cut shares of Aurora Cannabis from a “buy” rating to a “neutral” rating and set a $7.30 target price on the stock. in a research report on Thursday, July 18th. ValuEngine raised shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a research report on Wednesday, August 21st. LADENBURG THALM/SH SH initiated coverage on shares of Aurora Cannabis in a research report on Wednesday, July 17th. They set a “buy” rating and a $9.00 price target on the stock. Finally, Zacks Investment Research raised shares of Aurora Cannabis from a “sell” rating to a “hold” rating in a research report on Thursday. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Aurora Cannabis presently has a consensus rating of “Buy” and a consensus price target of $8.23.

ACB stock traded up $0.06 during midday trading on Friday, reaching $5.95. 12,440,595 shares of the company’s stock traded hands, compared to its average volume of 11,649,882. The company has a market capitalization of $6.62 billion, a P/E ratio of -27.05 and a beta of 2.47. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.37 and a quick ratio of 1.98. Aurora Cannabis Inc has a fifty-two week low of $4.58 and a fifty-two week high of $12.52. The business has a 50-day moving average price of $6.06 and a two-hundred day moving average price of $7.66.

Aurora Cannabis Company Profile

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Recommended Story: What is dollar cost averaging (DCA)?

Institutional Ownership by Quarter for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.